Evidence map›Paper›PMID 36982942›Full record

ArticleInternational journal of molecular sciences2023

Pieter Van den Abbeele, Mallory Goggans, Stef Deyaert, Aurélien Baudot, Michiel Van de Vliet, Marta Calatayud Arroyo, Michael Lelah

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel primers to identify a wider diversity of butyrate-producing bacteria.World journal of microbiology & biotechnology · 2024
    Article
  5. Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Pieter Van den AbbeeleCryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium.
Mallory GoggansNutriScience Innovations, 130C Old Gate Lane, Milford, CT 06460, USA.
Stef DeyaertCryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium.
Aurélien BaudotCryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium.
Michiel Van de VlietCryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium.ORCID 0000-0001-9755-7945
Marta Calatayud ArroyoInstitute of Agrochemistry and Food Technology (IATA), Spanish Research Council (CSIC), Carrer del Catedràtic Agustín Escardino Benlloch, 7, 46980 Valencia, Spain.ORCID 0000-0003-3592-3377
Michael LelahNutriScience Innovations, 130C Old Gate Lane, Milford, CT 06460, USA.
Ghent University · BEInstituto de Agroquímica y Tecnología de Alimentos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modulation of the gut microbiota is a trending strategy to improve health. While butyrate has been identified as a key health-related microbial metabolite, managing its supply to the host remains challenging. Therefore, this study investigated the potential to manage butyrate supply via tributyrin oil supplementation (TB; glycerol with three butyrate molecules) using the ex vivo SIFR

Indexed as

Lacticaseibacillus rhamnosusLimosilactobacillus reuteriProbioticsAdultButyratesGlycerolHumansLacticaseibacillusTriglyceridesButyratesGlyceroltributyrinTriglyceridesbutyrateex vivogut microbiotaLacticaseibacillus rhamnosus LGGLimosilactobacillus reuteriprebioticprobioticSIFR®synbiotictributyrin

Identifiers

PMID36982942
PMCPMC10054277
OpenAlexW4327957552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.